CRYM suppresses glioblastoma progression by inhibiting the TGFβ1/Smad-EMT signaling pathway. - Xu Y; Zhao P; Yao Z; Shen T; Ding S; Hua Y; Zhang F; Jiang X; Di G; Xia H (Journal of neuro-oncology, 2026)